PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,646 | -19.8% | 17,420 | 0.0% | 0.00% | – |
| Q2 2023 | $28,221 | +17.8% | 17,420 | +54.9% | 0.00% | – |
| Q1 2023 | $23,958 | -53.0% | 11,248 | +77.7% | 0.00% | – |
| Q4 2021 | $51,000 | -44.0% | 6,330 | -53.0% | 0.00% | – |
| Q2 2021 | $91,000 | -22.9% | 13,481 | -24.7% | 0.00% | – |
| Q1 2021 | $118,000 | -47.1% | 17,913 | -53.8% | 0.00% | – |
| Q3 2019 | $223,000 | -36.8% | 38,742 | 0.0% | 0.00% | – |
| Q2 2019 | $353,000 | -26.0% | 38,742 | +12.6% | 0.00% | – |
| Q1 2019 | $477,000 | -28.4% | 34,397 | -18.5% | 0.00% | – |
| Q4 2018 | $666,000 | – | 42,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |